ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,638Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 1000

$1.02M Total Retail Price of All Prescriptions

Rank: 45 out of 1000

649 Patients Receiving at Least One Drug in Part D
53%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 649 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

29% of this provider’s 649 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 10,510 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,324 562 S3 1 1
SIMVASTATIN 669 435 2 3
OMEPRAZOLE 600 341 3 2
LISINOPRIL 505 298 4 5
LEVOTHYROXINE SODIUM 446 290 5 4
TRAMADOL HCL 443 231 6 13
HYDROCHLOROTHIAZIDE 411 259 7 9
METFORMIN HCL 387 237 8 8
FUROSEMIDE 376 251 9 7
MELOXICAM 350 228 10 14
AMLODIPINE BESYLATE 320 194 11 6
ATORVASTATIN CALCIUM 269 178 12 18
GABAPENTIN 240 130 13 11
ATENOLOL 228 154 14 24
METFORMIN HCL ER 212 111 15 44
NEXIUM 204 121 16 23
LOSARTAN POTASSIUM 196 161 17 25
POTASSIUM CHLORIDE 192 106 18 10
CITALOPRAM HBR 186 106 19 17
CARVEDILOL 184 144 20 15
WARFARIN SODIUM 184 128 20 22
ZOLPIDEM TARTRATE 168 120 22 16
CLONIDINE HCL 166 95 23 27
PANTOPRAZOLE SODIUM 161 125 24 28
AZITHROMYCIN 160 83 25 36
PAROXETINE HCL 159 82 26 63
TAMSULOSIN HCL 153 95 27 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 148 101 28 20
SINGULAIR 144 81 29 84
METOPROLOL TARTRATE 143 67 30 19
DOXAZOSIN MESYLATE 140 117 31 111
RAMIPRIL 140 100 31 77
RANITIDINE HCL 138 43 33 37
DONEPEZIL HCL 133 120 34 32
LYRICA 130 35 35 47
BUPROPION XL 126 62 36 207
FENOFIBRATE 125 54 37 55
CRESTOR 118 67 38 30
ISOSORBIDE MONONITRATE ER 118 103 38 71
MONTELUKAST SODIUM 118 67 38 132
AMITRIPTYLINE HCL 116 77 R 41 45
CLOPIDOGREL 109 85 42 35
ROPINIROLE HCL 109 56 42 82
TRICOR 107 45 44 141
CYCLOBENZAPRINE HCL 106 43 R 45 39
ACTOS 103 69 46 119
METOPROLOL SUCCINATE 95 62 47 21
NAMENDA 95 92 47 43
CELEBREX 94 51 49 98
SPIRIVA 94 64 49 64
SERTRALINE HCL 89 43 51 26
KLOR-CON M20 87 81 52 66
TIZANIDINE HCL 87 50 52 76
NIASPAN 84 75 54 172
TRAZODONE HCL 81 44 55 29
LOSARTAN-HYDROCHLOROTHIAZIDE 80 52 56 38
LOVASTATIN 77 63 57 41
ESCITALOPRAM OXALATE 76 22 58 60
VERAPAMIL ER 75 47 59 86
PLAVIX 72 56 60 49
GLIMEPIRIDE 72 46 60 34
PRAVASTATIN SODIUM 71 31 62 12
CYMBALTA 71 18 62 53
BACLOFEN 70 0 64 129
FAMOTIDINE 68 33 65 88
AGGRENOX 67 55 66 243
NAPROXEN 67 39 66 81
QUINAPRIL HCL 66 24 68 117
GLIPIZIDE 66 51 68 62
PIOGLITAZONE HCL 64 45 R 70 253
SEROQUEL XR 64 0 70 238
PROAIR HFA 63 24 72 50
ALLOPURINOL 60 45 73 31
METOLAZONE 58 41 74 167
DILTIAZEM 24HR CD 58 56 74 136
METOCLOPRAMIDE HCL 57 21 76 99
LEVETIRACETAM 57 0 76 128
LACTULOSE 56 0 78 162
VENLAFAXINE HCL ER 56 0 78 124
QUETIAPINE FUMARATE 55 13 80 75
DIOVAN 55 42 80 67
DIVALPROEX SODIUM 55 0 80 113
MECLIZINE HCL 53 48 83 80
AMLODIPINE BESYLATE-BENAZEPRIL 52 27 84 59
TRIAMTERENE-HCTZ 52 36 84 48
COMBIVENT 52 40 84 193
TOPIRAMATE 51 0 87 181
SYNTHROID 51 27 87 91
ADVAIR DISKUS 50 36 89 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.